Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2
06/08/2026 21:06
BRIEF-Puma Biotechnology Q2 Adjusted EPS USD 0.2 Aug 06 (Reuters) - Puma Biotechnology Q2 EPS USD 0.16.
- Q2 net income USD 8.2 million
- Q2 adjusted net income USD 10.1 million
- Q2 product revenue USD 53.6 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2